Mirella Ezban

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

High Throughput

Palliative Care

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Annette Elizabeth Bowyer, Kieron Hickey, Steve Kitchen, Mirella Ezban
A next generation FVIII mimetic bispecific antibody, Mim8, the impact on non-factor VIII related haemostasis assays. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Judi Møss, Wan Hui Ong Clausen, Mirella Ezban
Measuring factor VIII activity in samples from patients treated with N8-GP (Esperoct® ; turoctocog alfa pegol) during the pathfinder clinical trials programme. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2020)
Stefan Tiefenbacher, Wan Hui Ong Clausen, Martin Hansen, Rasmus Lützhøft, Mirella Ezban
A field study evaluating the activity of N8-GP in spiked plasma samples at clinical haemostasis laboratories. Haemophilia : the official journal of the World Federation of Hemophilia 25 (5) (2019)
Junjiang Sun, Eric W Livingston, Mie L Broberg, Peter B Johansen, Carsten Dan Ley, Tom Knudsen, Mirella Ezban, Ted Bateman, Paul E Monahan, Sarah Taves
Prophylactic administration of glycoPEGylated factor IX provides protection and joint outcome superior to recombinant factor IX after induced joint bleeding. Journal of thrombosis and haemostasis : JTH 17 (8) (2019)
Mirella Ezban, Mette Brunsgaard Hermit, Egon Persson
FIXing postinfusion monitoring: Assay experiences with N9-GP (nonacog beta pegol; Refixia® ; Rebinyn® ). Haemophilia : the official journal of the World Federation of Hemophilia 25 (1) (2019)
Mirella Ezban, Martin Hansen, Marianne Kjalke
An overview of turoctocog alfa pegol (N8-GP; ESPEROCT® ) assay performance: Implications for postadministration monitoring. Haemophilia : the official journal of the World Federation of Hemophilia 26 (1) (2019)